Reuters reports Pfizer is weighing OTC options

10 November 2016 - Deborah Wilkes

Archived

Pfizer is evaluating a potential sale or spin-off for its Consumer Healthcare business, according to a Reuters news story. The report comes a few days after Pfizer's chairman and chief executive officer Ian Read said the pharmaceutical company continued to test all of its businesses, including Consumer Healthcare, to see if they were "worth more inside or outside of Pfizer".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: